Israeli company donating to US over 6 million doses of potential coronavirus cure

Israeli pharmaceutical company Teva is donating to US hospitals over 6 million doses of hydroxychloroquine sulfate, a medicine that may cure patients of COVID-19. Already approved by the US Food and Drug Administration (FDA) for treating malaria, lupus erythematosus and rheumatoid arthritis, the drug raised hopes after a study in France found it had killed the virus in 26 patients.

The post Israeli company donating to US over 6 million doses of potential coronavirus cure appeared first on Worthy Christian News.